Literature DB >> 27025948

SIADH: differential diagnosis and clinical management.

Alessandro Peri1, Christian Grohé2, Rossana Berardi3, Isabelle Runkle4.   

Abstract

Despite the widespread prevalence of hyponatremia and its deleterious effects on patients, it is often overlooked and consequently undertreated. This set of four cases provides practical advice on how to identify, diagnose, and treat patients with syndrome of inappropriate antidiuretic hormone (SIADH). The first steps that a physician should take when diagnosing a patient with hyponatremia are to assess the severity of neurological symptoms, and check the patient's volemic status in order to determine whether emergency treatment with hypertonic saline is indicated. Laboratory tests are necessary for the diagnosis of SIADH, but, in severe, symptomatic cases of hyponatremia, patients need treatment before the results of laboratory tests can be obtained. In this series, Case 1 demonstrates how awareness of hyponatremia led to early diagnosis and treatment. Case 2 demonstrates how multiple causes of hyponatremia can be diagnosed and managed sequentially. Case 3 illustrates how a patient with severe symptoms should be treated while waiting for laboratory test results to confirm diagnosis. Case 4 examines how the priorities of a patient should inform the management of their chronic SIADH, using palliative care of a patient with small-cell lung cancer as an example. There are several factors that clinicians should consider when making treatment decisions, including signs and symptoms, risks and benefits of different treatments, psychosocial factors, and the patient's wishes. All the available treatment options have a place in the management of patients with SIADH, and a physician should individualize decisions based on a patient's needs and priorities.

Entities:  

Keywords:  Diagnosis; Hyponatremia; Management; Syndrome of inappropriate antidiuretic hormone secretion

Mesh:

Year:  2016        PMID: 27025948     DOI: 10.1007/s12020-016-0936-3

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  30 in total

1.  Awareness and management of hyponatraemia: the Italian Hyponatraemia Survey.

Authors:  C Giuliani; M Cangioli; P Beck-Peccoz; M Faustini-Fustini; E Fiaccadori; A Peri
Journal:  J Endocrinol Invest       Date:  2013-04-02       Impact factor: 4.256

Review 2.  Review and analysis of differing regulatory indications and expert panel guidelines for the treatment of hyponatremia.

Authors:  Joseph G Verbalis; Ashley Grossman; Charlotte Höybye; Isabelle Runkle
Journal:  Curr Med Res Opin       Date:  2014-05-14       Impact factor: 2.580

3.  Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management.

Authors:  Ewout J Hoorn; Jan Lindemans; Robert Zietse
Journal:  Nephrol Dial Transplant       Date:  2005-09-02       Impact factor: 5.992

4.  Oral tolvaptan is safe and effective in chronic hyponatremia.

Authors:  Tomas Berl; Friederike Quittnat-Pelletier; Joseph G Verbalis; Robert W Schrier; Daniel G Bichet; John Ouyang; Frank S Czerwiec
Journal:  J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 10.121

5.  Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations.

Authors:  Joseph G Verbalis; Steven R Goldsmith; Arthur Greenberg; Cynthia Korzelius; Robert W Schrier; Richard H Sterns; Christopher J Thompson
Journal:  Am J Med       Date:  2013-10       Impact factor: 4.965

6.  Perspectives on the management of hyponatraemia secondary to SIADH across Europe.

Authors:  Ewout J Hoorn; Pierre-Marc Bouloux; Volker Burst
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-03       Impact factor: 4.690

Review 7.  Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH).

Authors:  A Peri; N Pirozzi; G Parenti; F Festuccia; P Menè
Journal:  J Endocrinol Invest       Date:  2010-10-08       Impact factor: 4.256

Review 8.  The urine/plasma electrolyte ratio: a predictive guide to water restriction.

Authors:  H Furst; K R Hallows; J Post; S Chen; W Kotzker; S Goldfarb; F N Ziyadeh; E G Neilson
Journal:  Am J Med Sci       Date:  2000-04       Impact factor: 2.378

9.  Treatment of euvolemic hyponatremia in the intensive care unit by urea.

Authors:  Guy Decaux; Caroline Andres; Fabrice Gankam Kengne; Alain Soupart
Journal:  Crit Care       Date:  2010-10-14       Impact factor: 9.097

10.  Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis.

Authors:  Giovanni Corona; Corinna Giuliani; Joseph G Verbalis; Gianni Forti; Mario Maggi; Alessandro Peri
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

View more
  8 in total

1.  Study on the Features of Clinical Imaging Diagnosis of Arteriosclerotic Encephalopathy.

Authors:  Wenbo Tang; Xiaoying Du; Wei Wang; Erbo Shan; Zhonglin Nie; Chaowen Yu; Yong Gao
Journal:  Comput Math Methods Med       Date:  2022-05-04       Impact factor: 2.809

2.  Improving care and outcomes of inpatients with syndrome of inappropriate antidiuresis (SIAD): a prospective intervention study of intensive endocrine input vs. routine care.

Authors:  Ploutarchos Tzoulis; Helen Carr; Emmanouil Bagkeris; Pierre Marc Bouloux
Journal:  Endocrine       Date:  2016-11-12       Impact factor: 3.633

Review 3.  Exercise-Associated Hyponatremia in Endurance and Ultra-Endurance Performance-Aspects of Sex, Race Location, Ambient Temperature, Sports Discipline, and Length of Performance: A Narrative Review.

Authors:  Beat Knechtle; Daniela Chlíbková; Sousana Papadopoulou; Maria Mantzorou; Thomas Rosemann; Pantelis T Nikolaidis
Journal:  Medicina (Kaunas)       Date:  2019-08-26       Impact factor: 2.430

Review 4.  Hypothalamic-Pituitary Axis Dysfunction, Central Diabetes Insipidus, and Syndrome of Inappropriate Antidiuretic Hormone Secretion as the First Clinical Presentation of Neurosarcoidosis: Why Early Diagnosis and Treatment is Important?

Authors:  Tatjana Blazin; Dhruvil Prajapati; Linha Lina M Mohammed; Meera Dhavale; Mohamed K Abdelaal; A B M Nasibul Alam; Natalia P Ballestas; Jihan A Mostafa
Journal:  Cureus       Date:  2020-11-14

5.  Hyponatremia and Encephalopathy in a 55-Year-old Woman with Syndrome of Inappropriate Antidiuretic Hormone Secretion as an Isolated Presentation of SARS-CoV-2 Infection.

Authors:  Andleeb Sherazi; Puneet Bedi; Ehizode Udevbulu; Vadim Rubin; Lutfi Alasadi; Samuel Spitalewitz
Journal:  Am J Case Rep       Date:  2021-03-24

Review 6.  A narrative review of progress in diagnosis and treatment of small cell lung cancer patients with hyponatremia.

Authors:  Ranpu Wu; Chuling Li; Zimu Wang; Hang Fan; Yong Song; Hongbing Liu
Journal:  Transl Lung Cancer Res       Date:  2020-12

7.  Syndrome of Inappropriate Antidiuretic Hormone Secretion as the Initial Presentation in a Patient with Stage I Small-cell Lung Cancer.

Authors:  Tomonobu Koizumi; Takashi Kobayashi; Shintaro Kanda; Toshirou Fukushima; Futoshi Muranaka; Kentaro Miura; Shiho Asaka
Journal:  Intern Med       Date:  2022-03-01       Impact factor: 1.271

Review 8.  Managing hyponatremia in lung cancer: latest evidence and clinical implications.

Authors:  Ilaria Fiordoliva; Tania Meletani; Maria Giuditta Baleani; Silvia Rinaldi; Agnese Savini; Marzia Di Pietro Paolo; Rossana Berardi
Journal:  Ther Adv Med Oncol       Date:  2017-10-28       Impact factor: 8.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.